英國(guó)BBI Solutions成立于1986年，是體外診斷試劑領(lǐng)域?qū)I(yè)制造商，為生命科學(xué)行業(yè)和體外診斷行業(yè)提供診斷試劑原料、標(biāo)準(zhǔn)品及技術(shù)服務(wù)，現(xiàn)已從一家小型專(zhuān)業(yè)公司成長(zhǎng)為業(yè)務(wù)生產(chǎn)基地橫跨三個(gè)國(guó)家的大型企業(yè)。

BBI Solutions主要經(jīng)營(yíng)產(chǎn)品包括人源抗原、抗體、血清、血漿、臨床化學(xué)酶和黃金納米顆粒。

BBI Solutions人源蛋白

BBI Solutions人源蛋白是從人類(lèi)血清或組織中純化所得，符合倫理法規(guī)要求；重組蛋白使用大腸桿菌和畢赤酵母表達(dá)系統(tǒng)，在專(zhuān)業(yè)的實(shí)驗(yàn)室中進(jìn)行生產(chǎn)；去血清產(chǎn)品，可顯著消除基質(zhì)效應(yīng)，提高生物標(biāo)志物的檢測(cè)效果，并產(chǎn)生可重復(fù)的標(biāo)準(zhǔn)曲線。

癌抗原CA19-9 CA19-9 Cancer Antigen 貨號(hào)：P291-4 

CA19-9 is elevated in blood, primarily in patients with carcinoma of the gastro-intestinal tract. Higher levels are more likely to be due to malignancy than lower levels, however very high levels are occasionally seen in patients with benign conditions such as cirrhosis. CA19-9 is not sufficiently specific for use as a screening test, its greatest usefulness is with pancreatic cancer compared with pancreatitis. The specificity for pancreatic cancer increases with increasing levels, high levels showing a specificity of >97%.

產(chǎn)品詳情：https://www.bbisolutions.com/cn/product/ca19-9

希凱生物是英國(guó)BBI Solutions授權(quán)代理商，更多產(chǎn)品信息，歡迎直接與我們聯(lián)系~